期刊文献+

河北省未治疗患者体内HIV毒株耐药基因检测研究 被引量:3

Study of genotypic antiretroviral resistance testing of HIV strains in untreated HIV/AIDS patients in Hebei province
下载PDF
导出
摘要 目的研究河北省未接受抗HIV治疗患者体内HIV毒株耐药突变情况,为开展临床抗病毒药物治疗和制定合理的用药方案提供数据支持。方法 RT-PCR技术扩增HIV pol区基因,双脱氧法测定HIV基因序列,并使用Contig Express软件处理原始核苷酸序列,与Stanford Hiv Drug Resistance Database(hivdb.stan-ford.edu)进行对比分析耐药突变情况。结果 10例患者HIV毒株基因亚型分析结果均为B亚型。发现存在大量逆转录酶和蛋白酶抑制剂继发耐药变异。结论河北省未治疗患者体内HIV继发耐药变异的存在提示要及早进行耐药检测,适时调整治疗方案。 Objective To study the drug resistance mutations of HIV-1 strains in untreated HIV/AIDS patients in Hebei province, and to provide the base-line data for clinical antiviral treatment and suitable therapeutic schedule. Methods The partial pol sequences were amplified by RT-PCR , then the gene segment was sequenced. The results of HIV genic sequence were treated by Contig Express and were compared with the Stanford Hiv Drug Resistance Database to analyze the state of HIV drug resisitance. Results ( 1 ) Phylogenetic analysis indicated that HIV genic subtypes of 10 patients were classified as subtype B. (2) Lots of secondary mutations were related with RT inhibitor and PI inhibitor. Conclusion The results reveals that untreated patients with HIV have acquired many secondary mutations in their PR and RT genes , which suggests us to pay much attention to the detection of drug resistance mutations and the adjustment of suitable therapeutic schedule in time.
出处 《河北医药》 CAS 2010年第12期1531-1533,共3页 Hebei Medical Journal
基金 河北省科学技术研究与发展指导计划项目(编号:08276101D-92)
关键词 HIV 未抗病毒治疗 基因型耐药性 human immunodeficiency virus non- antiviral teatment genotypic antiretroviral resistance
  • 相关文献

参考文献11

  • 1陈志强,梁良,李保军,王春燕,张彩雪,储俊武,李国浩.2007年河北省艾滋病病毒耐药检测结果分析[J].河北医药,2009,31(9):1129-1130. 被引量:10
  • 2Sarmati L,Nicastri E,Uccella I,et al.Drug associated resistance mutations in plasma and peripheral blood mononuclear cells of human immunodeficiency virus type 1 infected patients for whom highly active antiretroviral therapy is failing.J Clin Microbiol,2003,41:1760-1762.
  • 3Harrigan PR,Wynhoven B,Montaner J,et al.Mutations at reverse transcriptase codon 103:phenotypic resistance to non-nucleoside reverse transcriptase inhibitor and clinical correlates.Antiviral Therapy,2003,8:S120.
  • 4Servais J,Plesseria JM,Lambert C,et al.Genotypic correlates of resistance to HIV-1 protease inhibitors on longitudinal data:the role of secondary mutation.Antivir Ther,2001,6:239-248.
  • 5Geretti AM.Clinical implications of HIV drug resistance to nucleoside and nucleotide reverse transcriptase inhibitors.AIDS Rev,2006,8:210-220.
  • 6De Gruttola V,Dix L,D'Aquila R,et al.The relation between base-line HIV drug resistance and response to antiretroviral therapy:reanalysis of retrospective and prospective studies using a standardized data analysis plan.Antiviral Ther,2000,5:41-48.
  • 7赵翠英,邢辉,赵宏儒,黄海龙,刘艳芳,马鹏飞,李保军,张玉琪,王玉,邵一鸣.河北省HIV-1流行株的env基因序列测定和亚型分析[J].中华微生物学和免疫学杂志,2005,25(7):533-535. 被引量:19
  • 8赵翠英,邢辉,赵宏儒,何翔,路新利,辛若雷,李巧敏,程春林,李保军,邵一鸣.河北省2007年HIV-1流行毒株基因序列测定及亚型分析[J].中华流行病学杂志,2009,30(8):871-872. 被引量:9
  • 9Ivone LP,Marcelo AS,Francisco AB.Speranza,prevalence of human immunodeficiency virus drug resistance mutations and subtypes in drug-naive,infected individuals in the army health service of Rio de Janeiro,Brazil.J Clin Microbiol,2004,42:426-430.
  • 10Kiertiburanakul S,Sungkanuparph S.Emerging of HIV Drug Resistance:Epidemiology,Diagnosis,Treatment and Prevention.Curr HIV Res,2009,7:273-278.

二级参考文献17

共引文献31

同被引文献37

  • 1张旻,尚红,韩晓旭,张子宁,王亚男,刘宝贵,李秀金,刘静,姜拥军,王树祥,张岩,赵斌.中国东北地区未经抗病毒治疗的HIV/AIDS患者HIV毒株的耐药基因变异研究[J].中华微生物学和免疫学杂志,2004,24(11):850-854. 被引量:34
  • 2Sun J,Ma L, Yu X, et al. Replication and drug resistant mutation of HIV-1 subtype B' (Thailand B) variants isolated from HAART treatment individuals in China. Virol J,2009,6:201.
  • 3Mitra RD, Butty VL, Shendure J, et al. Digital genotyping and haplotyping with polymerase colonies. Proc Natl Acad Sci U S A, 2003,100:5926-5931.
  • 4Zhu J, Shendure J, Mitra RD, et al. Single molecule profiling of alternative pre-mRNA splicing. Science ,2003,301:836-838.
  • 5Petropoulos CJ, Parkin NT, Limoli KL, et al. A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1. Antimicrob Agents Chemother,2000,44:920-928.
  • 6Wang D, Hicks CB, Goswami ND, et al. Evolution of drug-resistant viral populations during interruption of antiretroviral therapy. J Viro1,2011,85 :6403-6415.
  • 7Liu J, Miller MD, Danovich RM, et al. Analysis of low-frequency mutations associated with drug resistance to raltega'avir before antiretroviral treatment. Antimicrob Agents Chemother, 2011,55 : 1114-1119.
  • 8Shafer RW. Low-abundance drug-resistant HIV-1 variants: finding significance in an era of abundant diagnostic and therapeutic options. J Infect Dis ,2009,199:610-612.
  • 9Metzner K J, Giulieri SG, Knoepfel SA, et al. Minority quasispecies of drug-resistant HIV-1 that lead to early therapy failure in treatment-naive and -adherent patients. Clin Infect Dis,2009,48: 239-247.
  • 10Johnson VA, Brun-Vezinet F, Clotet B, et al. Update of the drug resistance mutations in HIV-I: December 2010. Top HIV Med, 2010,18 : 156-163.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部